ARTICLE | Clinical News
Lamictal lamotrigine regulatory update
January 19, 2004 8:00 AM UTC
The FDA approved GSK's Lamictal as monotherapy to treat partial seizures in patients ages 16 and older when converting from valproate, which includes Depakene valproic acid and Depakote divalproex sod...